GlassScriptPhysician profile
James Romine
NPI 1366703845
$1,295.02
in general payments reported to CMS, 2019-2025
16 companies · $22.14 in 2025
The $22.14 reported for 2025 was less than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $425 · 2022: $147 · 2023: $311 · 2024: $390 · 2025: $22.14.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $723.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $722.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $355.99 | 2021 | |
| Smith+Nephew, INC. | $243.33 | 2021-2024 | Pico, Renasys Go V2 Home, Pico 14 |
| Ferring Pharmaceuticals INC. | $179.16 | 2021-2024 | Euflexxa |
| Convatec INC. | $94.30 | 2022 | |
| Bioventus LLC | $93.86 | 2021-2023 | Exogen Ultrasound Bone Healing System, Durolane |
| Providence Medical Technology, INC. | $76.21 | 2023 | |
| Aesculap, INC. | $56.04 | 2023 | Elan 4 |
| Stryker Corporation | $47.82 | 2023-2024 | Orthomap, Na |
| Cerapedics INC. | $31.11 | 2024 | I-Factor Peptide Enhanced Bone Graft |
| Heron Therapeutics, INC. | $22.83 | 2024 | Zynrelef |
| Medtronic, INC. | $22.14 | 2025 | Inceptiv |
| Depuy Synthes Sales INC. | $16.89 | 2023 | Monovisc, Orthovisc |
| Curonix LLC | $15.48 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Pacira Pharmaceuticals Incorporated | $15.03 | 2023 | Exparel, Iovera, Zilretta |
| Si-Bone, INC. | $13.22 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanos Medical | $11.61 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Romine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.